Boston Scientific Corp’s recently made public that its EVP & Group Pres, Cardiology Fitzgerald Joseph Michael unloaded Company’s shares for reported $4.92 million on Oct 01 ’25. In the deal valued at $98.47 per share,50,000 shares were sold. As a result of this transaction, Fitzgerald Joseph Michael now holds 178,342 shares worth roughly $16.93 million.
Then, JOSEPH M FITZGERALD bought 50,000 shares, generating $4,923,325 in total proceeds.
Before that, Fitzgerald Joseph Michael sold 50,000 shares. Boston Scientific Corp shares valued at $5,271,416 were divested by the EVP & Group Pres, Cardiology at a price of $105.43 per share. As a result of the transaction, Fitzgerald Joseph Michael now holds 178,342 shares, worth roughly $16.93 million.
Erste Group downgraded its Boston Scientific Corp [BSX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early September from “a Perform” to “an Outperform”. Leerink Partners began covering BSX with “an Outperform” recommendation on June 16, 2025. Needham revised its rating on April 16, 2025. It rated BSX as “a Buy” which previously was an “a Hold”.
Price Performance Review of BSX
On Monday, Boston Scientific Corp [NYSE:BSX] saw its stock fall -0.48% to $94.95. Over the last five days, the stock has lost -1.81%. Boston Scientific Corp shares have risen nearly 9.52% since the year began. Nevertheless, the stocks have risen 6.30% over the past one year.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-09-30, growing by 0.41 million shares to a total of 19.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 18.99 million shares. There was a rise of 2.11%, which implies that there is a positive sentiment for the stock.
